
Personalized CRISPR Therapy Successfully Treats Infant With Rare, Incurable CPS1 Deficiency
A personalized gene-editing therapy was safely delivered to an infant with a life-threatening, incurable genetic disease, explained Kiran Musunuru, MD, PhD, during a presentation at the 2025 American Society of Gene & Cell Therapy Annual Meeting (ASGCT …